Cytokine Networks Reprogram Bone Microenvironment to Foster Cancer Metastasis and Immunotherapy Resistance

Bone metastasis represents a significant clinical challenge in advanced cancers, frequently leading to progressive skeletal destruction and resistance to current immunotherapies. Despite the recognized importance of cytokines in both immune responses and bone remodeling, their integrated roles in shaping the bone metastatic niche remain largely underexplored. Current standard-of-care, including bone-modifying agents like RANKL inhibitors, often fails to prevent disease progression in a substantial subset of patients, highlighting a critical gap in understanding the underlying mechanisms of resistance and the need for novel therapeutic strategies.

Researchers synthesized existing knowledge to propose a conceptual framework detailing how cytokine-driven osteo-immune reprogramming shapes the bone microenvironment to support tumor persistence. This review systematically categorized cytokines into three functional groups: immune-dominant mediators, osteo-immune regulators, and divergent factors. The authors analyzed how these groups, rather than acting independently, form interconnected networks that establish reinforcing interactions, thereby stabilizing an immunologically cold and therapy-resistant niche. The approach involved a comprehensive literature review to integrate findings on cytokine biology, immunology, and bone metabolism within the context of cancer metastasis.

The proposed framework identifies that cytokine networks are central to establishing an osteo-immune microenvironment conducive to tumor growth and immune evasion. Cytokines were categorized into three functional groups: immune-dominant mediators (e.g., those primarily affecting immune cell function), osteo-immune regulators (e.g., those influencing both immune cells and osteoclasts), and divergent factors (e.g., those with context-dependent activities). These cytokines do not act in isolation but form complex, interconnected networks that create reinforcing feedback loops. This dynamic crosstalk between immune cells and bone cells, orchestrated by cytokines, leads to a state of immune suppression and accelerated osteoclastic bone destruction. The review emphasizes that immune resistance in bone metastasis is not solely due to tumor-intrinsic properties but emerges from this osteo-immune axis. Spatiotemporal regulation of cytokine signaling likely defines stage-specific vulnerabilities, offering opportunities for intervention.

These interconnected cytokine networks collectively stabilize an immunologically cold and therapy-resistant niche, fostering tumor persistence in the bone microenvironment.